Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
about
Biomechanics of vascular mechanosensation and remodelingSyndecan-4 Is an Independent Predictor of All-Cause as Well as Cardiovascular Mortality in Hemodialysis PatientsTransmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to HeparinRecent insights into the cellular biology of atherosclerosisThe arterial microenvironment: the where and why of atherosclerosis.The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of AtherosclerosisVascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point.Endothelial-to-mesenchymal transition drives atherosclerosis progression.Heparin Decreases in Tumor Necrosis Factor α (TNFα)-induced Endothelial Stress Responses Require Transmembrane Protein 184A and Induction of Dual Specificity Phosphatase 1.Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia.Endothelial fluid shear stress sensing in vascular health and disease.Fluid shear stress induces upregulation of COX-2 and PGI2 release in endothelial cells via a pathway involving PECAM-1, PI3K, FAK, and p38.Forces and mechanotransduction in 3D vascular biology.Minireview: Syndecans and their crucial roles during tissue regeneration.Endothelial Mechanosignaling: Does One Sensor Fit All?Blood Brothers: Hemodynamics and Cell-Matrix Interactions in Endothelial Function.Disturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events.Transforming Growth Factor-β1 Modulates the Expression of Syndecan-4 in Cultured Vascular Endothelial Cells in a Biphasic Manner.The molecular basis of endothelial cell plasticity.Coordination of Cellular Localization-Dependent Effects of Sumoylation in Regulating Cardiovascular and Neurological Diseases.Endothelial glycocalyx as a critical signalling platform integrating the extracellular haemodynamic forces and chemical signalling.Syndecan 4 controls lymphatic vasculature remodeling during mouse embryonic development.Engineered Microvasculature in PDMS Networks Using Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.Endothelial cells respond to the direction of mechanical stimuli through SMAD signaling to regulate coronary artery size.Syndecan-1 in mechanosensing of nanotopological cues in engineered materials.Regulation of vascular smooth muscle cell calcification by syndecan-4/FGF-2/PKCα signalling and cross-talk with TGFβ.Biglycan Intensifies ALK5-Smad2/3 Signaling by TGF-β1 and Downregulates Syndecan-4 in Cultured Vascular Endothelial Cells.
P2860
Q28067208-1A97D227-01D8-4565-BED7-5F6A024DDD18Q28554399-81601737-987A-4E98-9A8C-7C9FA1E36EECQ28567433-6B585301-BC14-4C0E-9C8F-FE19BDDA1525Q30300194-ADB50476-80E8-476D-9D64-468657B31C47Q33619657-26DEBF21-972B-42CE-9C2F-F58A294517D3Q33838927-74870CE8-80AD-46ED-93CE-4D98E89CF98FQ35111511-C44F99BE-B46F-4C02-ADC0-EEB554E8E20BQ36335841-11D5ADED-62AE-4F5D-A3DB-3473D963900CQ36650401-24F0FD78-3D0E-49D5-83B2-547C78C65901Q37285438-D0E7BE6F-3687-4D67-A813-9B011B8790D7Q38630594-F95AA9D9-F1E4-4DBD-992F-9432182EC15BQ38724570-2E77B4F3-509C-4655-8A64-712C1BBC7D01Q38840911-59CC2624-68D2-436E-9360-984AF6A177A4Q38887755-5E1A2B41-1DDA-433F-A7DB-473359CB6863Q38888511-A6554A5E-57EF-49D0-B233-2EF5321A640DQ38926872-1100D9E2-2817-41B0-9F28-681C4F6FDFECQ38926909-0B01F0BF-A9A0-4CAF-984A-48E031043BF1Q39064344-919DED79-FA79-4ACC-BB84-F936CBD55E32Q39127982-71966759-C06D-445F-863C-DF49156344D9Q39136019-429FE55F-25DD-4129-94D2-3F9615DE1ACFQ39140372-E86BB712-2F01-4316-B239-7ECDE5AFD30BQ46460268-D07ADB61-2C89-43DD-9918-43C4842F2A19Q46515077-47F885E0-3B24-4C21-9518-6827F3200D7AQ47197118-4ED6C099-2D7F-4005-AB0A-42814F7E858FQ47331122-B8800C93-E6E2-4947-AE51-1E5FCC772C44Q47583828-D948ED93-285E-40D7-A904-5A6F3BF87E0DQ51538543-1B940E38-9171-4B66-9C5B-1EF96277D652
P2860
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@ast
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@en
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@nl
type
label
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@ast
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@en
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@nl
prefLabel
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@ast
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@en
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@nl
P2093
P2860
P50
P356
P1476
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.
@en
P2093
Cecile O Mejean
Jay Humphrey
John M Rhodes
Martin A Schwartz
Mary Jo Mulligan-Kehoe
Thomas Z Wang
P2860
P304
17308-17313
P356
10.1073/PNAS.1413725111
P407
P577
2014-11-17T00:00:00Z